Cardiac Imaging

While cardiac ultrasound is the widely used imaging modality for heart assessments, computed tomography (CT), magnetic resonance imaging (MRI) and nuclear imaging are also used and are often complimentary, each offering specific details about the heart other modalities cannot. For this reason the clinical question being asked often determines the imaging test that will be used.

AI model turns POCUS images into accurate structural heart evaluations
Researchers see potential for this technology to make cardiac screening much easier for physicians who are not trained cardiologists.
FAPI PET shows promise to make a big impact in cardiovascular imaging
More and more imaging researchers are starting to examine the potential of using fibroblast activation protein inhibitors (FAPI) to manage patients with suspected cardiovascular disease.
Overview of the new GE HealthCare photon-counting scanner technology
Tim Szczykutowicz, PhD, associate professor radiology, University of Wisconsin Madison, explains the new technology developments in GE HealthCare's FDA 510(k)-pending photon-counting CT scanner.
Exploring major trends as IVL keeps evolving
Intravascular lithotripsy is expected to see even wider adoption when lower-profile catheters are introduced and device costs start to drop, explained Samin Sharma, MD.
Medtronic’s newest all-in-one PFA catheter gains critical approval
The all-in-one mapping and single-shot PFA catheter was developed with electrophysiologist feedback in mind.

Hospital patient bays recovery Banner Health and Atlas Ambulatory Surgical Center (ASC) in Sun City, Arizona.

Office-based interventional labs see boost in pay in 2026

CMS has made it a priority to increase payments for procedures performed by office-based labs and ambulatory surgical centers. This was reflected in policy changes made as part of the 2026 Medicare Physicians Fee Schedule.

ASNC reports shortage of cardiac amyloidosis radiotracers

The two vendors involved say supplies of PYP and HDP could be disrupted for months.

FDA clears MRI-compatible EP mapping catheter

This represents the first FDA clearance for Imricor Medical Systems. "It’s an exciting achievement and a date to be noted and remembered," CEO Steve Wedan said in a statement.

Boston Scientific Farapoint pulsed field ablation (PFA) catheter

FDA approves Boston Scientific’s Farapoint PFA catheter

The newest addition to the company's Farapulse PFA Platform was specifically approved to perform cavotricuspid isthmus ablation.

Mirvat Alasnag, MD, FACP, FACC, FSCAI, FSCCT, director of catheterization laboratory and research, King Fahd Armed Forces Hospital, Jeddah-Saudi Arabia, Ditrector of TCT Middle East, and member of Society of Cardiovascular CT (SCCT) Education Committee, explains how the society it translating its educational content into other languages to help a wider international audience of clinicians. SCCT is working to expand its international membership and this is a big part of that strategy.

SCCT expands CCTA education overseas

SCCT has made it a priority to help clinicians from all over the world learn more about CCTA as the modality continues to transform patient care.

PET-CT imaging of 124-I evuzamitide and SPECT-CT imaging of 99mTc-p5+14 showed radiotracer uptake in both AL and ATTR amyloid throughout the myocardium. Emily B. Martin, Anne Kassira, Alan Stuckey, et al. A tale of two tracers - Amyloid imaging with investigational radiotracers iodine (124I) evuzamitide and 99mTc-p5+14 (AT-05). https://www.journalofnuclearcardiology.org/article/S1071-3581(25)00325-3/abstract.

Bayer expands into molecular imaging with cardiac amyloidosis tracer acquisitions

Bayer is acquiring two cardiac amyloidosis radiotracers from Attralus, one for PET and one for SPECT. The SPECT tracer is also a theranostic agent to both image and treat amyloidosis.

Sunil Rao, MD, MSCAI, director, interventional cardiology, cardiac catheterization laboratory, NYU Langone Heart, professor, Department of Medicine, the Leon H. Charney Division of Cardiology, NYU Grossman School of Medicine, explains the prevalence, trends and predictors of same day discharge after percutaneous coronary intervention (PCI) data for non-ST-elevation acute coronary syndrome (NSTE-ACS) in clinical practice from the NCDR-CathPCI Registry.

Same-day discharge after PCI for NSTE-ACS is on the rise

Sunil Rao, MD, told Cardiovascular Business that same-day discharge is still relatively rare for these patients, but it appears to be growing more common over time. The COVID-19 pandemic appears to have played a key role in the development of this trend.

RSNA seeking new editor for cardiothoracic imaging journal

RSNA is looking for a replacement for Suhny Abbara, MD, who is now the editor-in-chief of its flagship journal.

Cardiac Imaging

AI model turns POCUS images into accurate structural heart evaluations

FAPI PET shows promise to make a big impact in cardiovascular imaging

Overview of the new GE HealthCare photon-counting scanner technology

Exploring major trends as IVL keeps evolving

Medtronic’s newest all-in-one PFA catheter gains critical approval